These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8727427)

  • 1. Quantitative structure--activity relationship (QSAR) studies of mutagens and carcinogens.
    Benigni R; Giuliani A
    Med Res Rev; 1996 May; 16(3):267-84. PubMed ID: 8727427
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring structure-activity relationships of mutagens and carcinogens.
    Benigni R
    Prog Clin Biol Res; 1991; 372():59-67. PubMed ID: 1956948
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology.
    Benigni R; Bossa C
    Chem Rev; 2011 Apr; 111(4):2507-36. PubMed ID: 21265518
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches.
    Benigni R
    Chem Rev; 2005 May; 105(5):1767-800. PubMed ID: 15884789
    [No Abstract]   [Full Text] [Related]  

  • 5. [A computer system of automated evaluation of structure-activity relationship of chemical mutagens].
    Fu ZD; Gu LJ; Chen WR
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Jan; 27(1):16-8. PubMed ID: 8325171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
    Benigni R
    J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Commission for Protection Against Environmental Mutagens and Carcinogens. Two million rodent carcinogens? The role of SAR and QSAR in their detection.
    Ashby J
    Mutat Res; 1994 Feb; 305(1):3-12. PubMed ID: 7508545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR studies in genetic toxicology: congeneric and non congeneric chemicals.
    Benigni R; Giuliani A
    Arch Toxicol Suppl; 1992; 15():228-37. PubMed ID: 1510592
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the electrophilic reaction chemistry involved in covalent DNA binding.
    Enoch SJ; Cronin MT
    Crit Rev Toxicol; 2010 Sep; 40(8):728-48. PubMed ID: 20722585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk identification using structural concepts: the potential carcinogenicity of praziquantel.
    Rosenkranz HS; Zhang YP; Klopman G
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):152-61. PubMed ID: 8577950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity.
    Müller L; Mauthe RJ; Riley CM; Andino MM; Antonis DD; Beels C; DeGeorge J; De Knaep AG; Ellison D; Fagerland JA; Frank R; Fritschel B; Galloway S; Harpur E; Humfrey CD; Jacks AS; Jagota N; Mackinnon J; Mohan G; Ness DK; O'Donovan MR; Smith MD; Vudathala G; Yotti L
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):198-211. PubMed ID: 16412543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Commission for Protection Against Environmental Mutagens and Carcinogens. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program.
    Enslein K; Gombar VK; Blake BW
    Mutat Res; 1994 Feb; 305(1):47-61. PubMed ID: 7508547
    [No Abstract]   [Full Text] [Related]  

  • 16. QSARS of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals.
    Benigni R; Richard AM
    Mutat Res; 1996 Nov; 371(1-2):29-46. PubMed ID: 8950348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of neural networks to large dataset QSAR, virtual screening, and library design.
    Winkler DA; Burden FR
    Methods Mol Biol; 2002; 201():325-67. PubMed ID: 12357937
    [No Abstract]   [Full Text] [Related]  

  • 18. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity models of chemical carcinogens: state of the art, and new directions.
    Benigni R; Bossa C
    Ann Ist Super Sanita; 2006; 42(2):118-26. PubMed ID: 17033131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenic and carcinogenic structural alerts and their mechanisms of action.
    Plošnik A; Vračko M; Dolenc MS
    Arh Hig Rada Toksikol; 2016 Sep; 67(3):169-182. PubMed ID: 27749264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.